Purpose. Amikacin is one of the most effective antibiotics against Pseudomonas aeruginosa infections, but because of its high toxicity, the use of this antibiotic has been clinically limited. In the present study, amikacin was successfully loaded into a new formulation of nanoparticles (NPs) based on poly(D,L-lactide-co-glycolide) 50 : 50 in order to enhance the treatment efficacy. The synthetized amikacin-loaded PLGA nanoparticles with high drug loading and stability were used to eliminate P. aeruginosa cells in planktonic and biofilm states.
INTRODUCTION
Pseudomonas aeruginosa is one of the most important opportunistic respiratory pathogens, especially in immunocompromised individuals and patients suffering from cystic fibrosis or burn wound infections [1] , due to several mechanisms of resistance (e.g. outer membrane permeability and the capability to form biofilms) [2] [3] [4] . Biofilms produced by Pseudomonas cause chronic infections because they show a higher resistance to the host immune system recognition and effector processes, such as phagocytosis, than planktonic cells do [5] . In addition, bacteria living in biofilms undergo several shifts in gene regulation, which cause significant phenotypic changes leading to a broad resistance to antibiotic therapies, among others, lower membrane permeability and metabolic activities, increased expression of b-lactamases, upregulation of efflux pumps and dormancy [6] [7] [8] [9] [10] . Furthermore, the bacteria are embedded in a self-produced polymeric matrix that can prevent the penetration of antibiotics. A mature biofilm contains different newly created micro-habitats characterized by sharp gradients that must be taken into account, since small variations in growth factors, dissolved oxygen or hydrogen ion concentration can affect the antibiotic uptake [11] .
Aminoglycosides are one of the most effective families of antibiotics generally used in the treatment of P. aeruginosa infections; in particular, amikacin is the second drug of choice for cystic fibrosis centres and nosocomial infections [12, 13] .
Being cationic, aminoglycoside antibiotics also cause membrane damage and altered ionic concentration [13, 14] . However, amikacin belongs to the category of cationic agents and is likely to bind to negatively charged polymers delaying penetration through the biofilm. Additionally, due to their nephrotoxicity and ototoxicity, aminoglycosides are prescribed in limited and controlled doses [15] [16] [17] . The loading of amikacin into drug delivery systems like nanoparticles (NPs) may potentially overcome some of these drawbacks. Thus, the small size of NPs as well as the appropriate selection of their surface properties facilitates their transfer through biological barriers, including biofilms [18] . In this way, the required amount of drug will decrease, its side effects will be eliminated and it will be able to transfer to the target site without any damage to the tissues and non-target cells [19] .
In the present study, the synthesized amikacin-loaded poly (D,L-lactide-co-glycolide) (PLGA) NPs with high drug loading and stability were used to eliminate P. aeruginosa cells in planktonic and biofilm states. The ability of NPs to interact and eradicate the bacterial cells even in the form of biofilms was investigated using confocal laser scanning microscopy (CLSM). The good antibacterial and antibiofilm activities of amikacin-loaded NPs (A-NPs), in addition to their ability to enter macrophages without any cytotoxicity for these cells, make them a potential candidate to treat P. aeruginosa infections.
METHODS

Materials
Amikacin hydrate was from TOKU-E. PLGA 50 : 50 (Resomer RG 502 h) was obtained from Boehringer-Ingelheim. Pluronic F-68 was from Sigma-Aldrich. Fluoraldehyde o-phthalaldehyde reagent solution was from Thermo Scientific. Bromoethylamine hydrobromide and Concanavalin A-FITC conjugate, type IV (ConA-FITC), were from Sigma-Aldrich. Luria-Bertani (LB) broth was purchased by Pronadisa. Lumogen fluorescent red 305 was from Kremer.
Preparation and characterization of NPs
A-NPs were prepared by a solid-in-oil-in-water method, as described previously [20] . Briefly, amikacin was dissolved in ultrapure water. The drug solution was then added to acetone containing PLGA. The s/o phase was added to a 25 mM MES buffer solution (pH 10) containing pluronic F-68. Finally, A-NPs were freeze dried in the presence of 5 % sucrose for 72 h. Blank NPs were prepared as a control in the same way as described above but in the absence of amikacin.
For some studies, fluorescently labelled NPs were used. For this purpose, Lumogen fluorescent red dye was dissolved in the acetone solution (0.2 mg ml À1 ) containing PLGA. Then, NPs were obtained and dried in the same way as previously mentioned. These fluorescent A-NPs and fluorescent blank NPs were identified as FA-NPs and F-NPs, respectively.
NPs were characterized in terms of size, zeta potential and drug loading. The mean size and the zeta potential of freeze-dried NPs were determined by photon correlation spectroscopy and electrophoretic laser Doppler anemometry, respectively, using a Zetaplus apparatus (Brookhaven Instruments Corporation). In all cases, the size was measured after dispersion of NPs in water, whereas the zeta potential was quantified in KCl 0.1 M.
Drug release kinetics were investigated in phosphate buffer pH 7.4 at 37 C. The amount of amikacin was determined using the fluoraldehyde o-phthalaldehyde reagent solution and measuring the resulting fluorescence at l ex /l em of 340/ 450 (Tecan GENios fluorimeter; Tecan Group).
Antibacterial susceptibility testing Planktonic cells
To check the antimicrobial efficacy of the loaded drug against planktonic cells of P. aeruginosa PAO1, antibacterial susceptibility tests were done in LB medium for free drug, A-NPs and NPs using a broth microdilution method, as described previously [20] .
Biofilm cells
Minimum biofilm eradication concentration (MBEC)
P. aeruginosa PAO1 biofilm susceptibility assays were done using the MBEC Assay for Physiology and Genetics (P&G) (Innovotech). Diluted PAO1 suspension (150 µl, 10 5 c.f.u. ml
À1
) was added to each well of a MBEC plate and incubated for 24 h at 37 C and 120 r.p.m. to form biofilm on the pegs of the MBEC plate lid. After 24 h, pegs were immersed twice in sterile 0.9 % NaCl (170 µl well
) to remove unattached bacteria. Then, they were challenged with twofold serial concentrations (4-512 µg ml À1 ) of free amikacin or ANPs in 170 µl media (three replicates per condition) and incubated as described. A volume of 85 µl from each well of the biofilm formation microtitre plate was transferred to another microtitre plate containing 85 µl of twofold serial concentrations of free amikacin or A-NPs to determine the MIC and minimum bactericidal concentration (MBC) of planktonic cells shed from the formed biofilm.
After treatment, pegs were rinsed as described and placed in a recovery plate containing 170 µl of sterile 0.9 % NaCl per well. Biofilms were detached by ultrasonic treatment for 10 min. Aliquots of 10 µl from each well were cultured on tryptic soy agar (TSA) plates. The plates were incubated for 24 h at 37 C. The lowest concentration of treatment at which no growth was seen after 24 h was determined as the MBEC.
To determine the MIC of planktonic cells shed from biofilm exposed to treatments, 85 µl from each well of the challenge plate was transferred to another microtitre plate containing 85 µl of fresh LB medium. The plate was incubated for another 24 h at 37 C. In order to determine the MBC of these cells, 10 µl from each well of the challenge plate was transferred to TSA plates and incubated for 24 h at 37 C [21] . CLSM studies were performed as described before [22] . Briefly, 24 h after the P. aeruginosa PAO1 biofilm exposure to MBEC of A-NPs or free amikacin, the pegs were rinsed twice with 0.9 % NaCl and then stained. The cells inside the biofilm were stained using Live/Dead BacLight Bacterial Viability Kit Syto 9/PI (L7007) (Molecular Probes) following the company protocol. The kit consists of two nucleicacid-binding stain mixtures: Syto 9 and propidium iodide. Syto 9 stains all viable bacteria green, and propidium iodide stains the bacteria with damaged membranes (dead bacteria) red. Three independent pegs were used for each of the treatments, and three untreated pegs were used as the control. In all cases, labelled biofilms were placed in a drop of 0.9 % NaCl. The pegs were studied using a Zeiss LSM 800 confocal microscope with excitation at 488 and 561 nm. All samples were sequentially scanned, frame by frame, first at 495 to 571 nm and then at 571 to 700 nm. Fluorescence emission was then sequentially collected in the green and red regions of the spectrum, respectively. An oil immersion objective Â63 was used in all the experiments. Images were captured with 512Â512 resolution in at least three different regions of each peg. To determine the biofilm maximum thickness, at least 10 different regions per peg were analysed, by determining the top and bottom layers of the biofilm and calculating the maximum thickness of each region. Image capture and two-dimensional projections of z-stacks were performed using the ZEN lite 2011 software (Carl Zeiss Micro Imaging), three-dimensional (3D) reconstructions were performed using the Zen blue 2012 software (Carl Zeiss Micro Imaging) and cell counting was done using ImageJ software (US National Institutes of Health; http:// imagej.nih.gov/ij/).
NP interaction with bacteria Planktonic cells
To prevent flow cytometer contamination with P. aeruginosa, we used inactivated bacteria. Bacteria were inactivated using binary ethylenimine (BEI) in combination with formaldehyde [23] . BEI is an alkylating substance specific for the nucleic acids, which is widely used in virus vaccine production. It intercalates with nucleic acids and does not interact with proteins; therefore, it is not expected to modify bacterial surface properties. BEI was prepared by cyclization of 0.1 M bromoethylamine hydrobromide in 0.175 M NaOH solution for 1 h at room temperature according to the method of Bahnemann [24] . The cyclization of 0.1 M 2-bromoethylamine into the active BEI form was confirmed by the change in pH, from 12.7 to 8.7. The solution was freshly prepared prior to each experiment. BEI in combination with formaldehyde was added to bacteria suspensions in the stationary phase and incubated at 37 C with continuous stirring up to 6 h. Every hour, 1 ml of the suspension was directly spread onto a TSA plate, incubated at 37 C and checked for growth during 7 days. Full bactericidal activity was considered to be when no colonies appeared after 7 days of incubation.
The inactivated bacteria were centrifuged and washed twice with PBS 10 mM, pH 7.4 (PBS), at 6000 g for 15 min. The resulting pellets were resuspended in PBS to approximately 10 8 c.f.u. ml
À1
. The bacterial suspension was added to an equal volume of 0.1 mg ml À1 of fluorescent NP suspension and mixed gently for 10 min at 15 oscillations per minute. The same method was used for particle-free, sterile PBS as a control. Exposure was ended by centrifugation. The pellets were resuspended in 1 ml of PBS. Experiments were repeated in triplicate.
Flow cytometric analysis (Attune Acoustic Focusing Cytometer) was used to evaluate NP adhesion to bacteria. Ten thousand events were counted, and analysis was carried out using side scatter (SSC) versus fluorescence plots. All experiments were done three times. Data were analysed using Attune Cytometric software.
Biofilm cells
After biofilm formation on the pegs, they were washed twice and exposed to 200 µl of 0.1 mg ml À1 FA-NP suspension for 1 h at 37 C. Then, the NPs which had no interaction with formed biofilm were removed by washing twice. To stain the biofilm matrix, pegs were incubated with 200 µl of 50 µg ml À1 ConA-FITC for 2 h at 37 C. Pegs were rinsed and analysed using CLSM with excitation at 488 and 561 nm. Three independent pegs were used. The pegs were placed in a drop of 0.9 % NaCl and were sequentially scanned, frame by frame, first at 400 to 562 nm and then at 622 to 700 nm. Fluorescence emission was then sequentially collected in the green and red regions of the spectrum, respectively. An oil immersion objective Â63 was used in all the experiments. Images were captured with 512Â512 resolutions in at least three different regions of each peg. 3D reconstructions were performed using ZEN blue 2012 software.
NP uptake by mouse macrophages
Cell viability and toxicity assay NP cytotoxicity (0.01-1 mg ml À1 ) was evaluated by MTT, Alamar blue, neutral red and lactate dehydrogenase assays using the mouse macrophage cell line RAW 264.7 (ATCC TIB-71), as described previously [20] . Since NPs showed no cytotoxicity for the macrophage RAW 264.7 cell line, the cell ability to uptake the NPs was investigated to estimate their potential ability to be used against P. aeruginosa residing inside the macrophages.
Flow cytometry analysis RAW macrophages were kept in RPMI medium 1640, supplemented with 1 % penicillin-streptomycin (10.000 U ml À1 ; Gibco) and 10 % foetal bovine serum (Gibco) at 37 C in a humidified 5 % CO 2 atmosphere. Briefly, 10 5 cell well À1 was seeded in 96-well plates and incubated for 24 h at 37 C in a humidified 5 % CO 2 atmosphere. After washing the cells with PBS, 100 µl of freshly prepared FA-NPs in the respective medium was added to each well (0.1 and 0.5 mg ml À1 ). One set of controls treated with culture medium was also included. Cells were exposed to NPs for 2 and 24 h at 4 and 37 C in a humidified 5 % CO 2 atmosphere. After the predetermined period, the wells were washed three times to remove extra unattached NPs. To detach the cells, they were treated with 0.05 % trypsin-EDTA (Gibco) and then diluted in the respective medium. Cell suspensions were analysed using flow cytometric analysis. Ten thousand events were analysed using forward scatter (FSC) versus fluorescence and SSC versus fluorescence plots. All experiments were done at least three times. Data were analysed using Attune Cytometric software.
CLSM studies
To verify NP uptake by macrophages, CLSM studies were performed. Briefly, 4Â10
4 cells were seeded in each well of a Lab-Tek chambered coverglass (Nunc) and incubated for 24 h as described above. Then, the supernatant was replaced with 100 µl of 0.1 mg ml À1 fluorescent NPs. The RAW macrophages were exposed to NPs for 2 and 24 h at 4 or 37 C in a humidified 5 % CO 2 atmosphere. At the end of the exposure time, the supernatants were removed, and the wells were rinsed three times with PBS. Cell membrane was labelled for 1 h with 10 µl ml À1 of a membrane marker, Vybrant DiO (Thermo Fisher Scientific), at 37 C under dark conditions. Labelling of the cells was stopped by washing three times with RPMI-supplemented medium. CLSM studies were done with excitation at 488 and 561 nm. The wells were sequentially scanned, frame by frame, at 400 to 569 nm and 591 to 700 nm. Fluorescence emission was then sequentially collected in the green and red regions of the spectrum, respectively. An oil immersion objective Â63 was used. Images were captured with 512Â512 resolutions and analysed using ZEN lite 2011 software.
Data analysis
All experiments were performed in triplicate and repeated at least three times. Data were expressed as mean±SD. Comparisons of two groups were made using ANOVA and Tukey's test in Minitab 15 statistical software.
RESULTS AND DISCUSSION
NP characterization
NPs presented mean diameters of 340±5 nm and a zeta potential of À42.8±1.5 mV. A-NP formulations resulted in particles with a mean diameter of 447±7 nm and a zeta potential of À29.8±1.5 mV. The negative surface charge reduction of the resulting NPs would be due to the hydrophilic character and positive charge of amikacin [25, 26] . Thus, during the formation of NPs, amikacin would accumulate on areas close to the surface of the resulting particles, and therefore, the negative zeta potential of NPs would be decreased. The amount of amikacin loaded was calculated to be 26 µg mg À1 PLGA.
Antibacterial susceptibility testing Planktonic cells
To ensure the functionality of the drug formulation, A-NPs, NPs and free amikacin were evaluated. As expected, the NPs showed no antibacterial activity. A-NPs showed MIC and MBC values two and three serial dilutions lower in comparison with free amikacin (4 vs 2 µg ml À1 and 32 vs 4 µg ml À1 , respectively).
Biofilm cells MBEC P. aeruginosa PA01 biofilms formed on the polystyrene pegs of the Calgary biofilm device were used for all the biofilm studies. The biofilms were treated with either free amikacin or A-NPs for 24 h, and the obtained MBEC values were 128 and 512 µg ml À1 , respectively. The higher MBEC values relative to the MBC of planktonic cells are likely due to biofilm structure and the interaction of the anionic matrix of biofilm with the cationic aminoglycoside, limiting the amount of free drug available to act against the bacteria inside the biofilm [27] . Similar results were obtained by Abdelghany et al. [28] , who reported about 30 times more resistance of P. aeruginosa PAO1 biofilm cells in comparison with P. aeruginosa PAO1 planktonic cells treated with free gentamicin or gentamicin-loaded PLGA NPs. However, despite the lower in vitro activity, the encapsulation of the drug in NPs offers alternative therapeutic advantages, as discussed in the following sections.
During biofilm development, several physiologically distinct phases occurred, including the detachment of some adhered bacteria. It has been shown that these detached cells from a mature Pseudomonas biofilm were more closely related to planktonic bacteria than to the mature biofilm cells [29] . In contrast, studies performed with Escherichia coli biofilms showed that the cells released from the biofilm were less hydrophobic than the attached ones [30] , suggesting a potential different sensitivity to environmental factors, although many other factors mediate in the process.
In order to study whether the higher MBEC obtained in our work was due to a misinterpretation caused by the higher resistance to amikacin of the detached cells, we compared the effect of amikacin on both planktonic cells released from biofilm versus planktonic cells from standard culture. The results indicated that there was no significant difference between the MIC of planktonic cells and the MIC of biofilm-derived planktonic cells which were 2 µg ml À1 when treated with free amikacin and 4 versus 8 µg ml À1 when treated with A-NPs, respectively.
CLSM analysis
In a step, results above, we studied the ability of the biofilm matrix to reduce antibiotic penetration in both cases, either free or loaded into NPs. There are at least two major problems attributed to aminoglycoside application to treat biofilm infections: limited penetration into the biofilm due to electrostatic interactions and biofilm formation induction in the presence of aminoglycosides in concentrations lower than the MIC [31] [32] [33] . In general, antibiotics can penetrate biofilms over long exposure times, but this is not the case with the positively charged aminoglycosides in the face of the mucoid negatively charged alginate matrix of the P. aeruginosa biofilm. On the other hand, the slow penetration of antibiotics into biofilms can provide the cells inside the biofilms the time they need to physiologically adapt to the antibiotic and reach a more antimicrobial tolerant state before killing concentrations of the antibiotic can be achieved [34] . Drug carriers used to treat biofilm infections should be able to penetrate deeply into the biofilm and also effectively transfer the drug to those regions. Using nanocarriers with controlled drug release is a way to overcome the problems discussed here. The penetration and activity of antibiotics through biofilms can be measured by different methodologies. In this study, to evaluate the efficacy of free and encapsulated amikacin in killing the bacteria that reside in the biofilm, a fluorescent live/dead staining procedure was used. The detection system consists of two fluorescent stains, Syto 9 and propidium iodide. When the cells are labelled only with Syto 9, live and dead cells stain green. On the other hand, propidium iodide is only able to enter the cells with damaged cell membranes. Therefore, the damaged cells will be seen in red and the live cells in green. Dead cells in which Syto 9 is not completely substituted with propidium iodide will be seen in yellow or orange [35] .
The biofilms formed on the polystyrene peg lids of the Calgary biofilm device were treated, stained and studied by CLSM. Under the specified experimental conditions, there was a significant decrease in bacterial cell number when treated with A-NPs in comparison to control and free amikacin-treated samples (Fig. 1) , particularly in the deepest z-stack corresponding to the section of biofilm attached to the peg surface. These results suggest that the NPs have the ability to penetrate the biofilm matrix and reach the deepest part of the matrix and, consequently, are able to transport amikacin straight to the deepest layers (Fig. 2) . To confirm this effectiveness, the percentage of bacterial cells in the total biofilm volume and on the deepest layer of the biofilm was determined by using a new plug-in for ImageJ software. Results indicate that the lowest number of total cell count was observed after treatment with A-NPs (Figs 1 and 2 ).
The thickness of biofilms formed on three different pegs and prepared in three different experiments with different inoculums was determined using fluorescent live/ dead staining. To properly define the cellular events, contouring (image segmentation) was performed from the stacks of their two-dimensional images. This approach enabled us to obtain topological information about the live/ dead cell ratio along the biofilm. Here, we defined the contour of the first stack with visible live/dead cells and the last one. Moreover, since biofilm formation on different areas of every single peg was not uniform, 10 different random fields of view on each peg were selected for biofilm thickness determination. Biofilms more than 30 µm thick were rarely found in the case of biofilms treated with A-NPs. Statistical analysis showed a significant difference between biofilm thickness treated with A-NPs and the control, while no significant difference was shown in the case of biofilm thickness treated with free amikacin (Fig. 3) .
The consistent presence of inhibitory concentrations of an antibacterial agent can be the best way to control the persister cells [36] and slow-growing cells, both inhabitants in the deeper layers of biofilms [31] and involved in biofilm resistance to antibiotics [6, 37] . Thus, the herein presented amikacin containing NPs that is able to reach that region and continuously release its drug content might, potentially, control both cell populations (Figs 1  and 2 ).
NP interactions with bacteria Planktonic cells
The mechanisms by which NPs interact with bacteria are diverse and it is critical to choose the correct antibacterial agent in order to fight the biofilm cells [38] . NPs are able to physically interact with the outer membrane of Gram-negative bacteria, allowing the adhesion and accumulation of NPs to the bacterial surface. This phenomenon can be exploited to enhance the accumulation of a high concentration of antibiotic close to the outer membrane, enabling the antibiotic to reach its target. The electrostatic forces are central parameters in the interaction between NPs and bacteria. Bacteria, with a negative surface charge, will be more closely attracted to positively charged particles [39] . Z-potential determination of NPs and A-NPs in addition to drug release kinetic studies suggests the drug presence on the surface of particles. Therefore, since amikacin contains several free amine groups, there is a potential interaction among these groups and the negatively charged bacteria. In the present study, according to the fast drug release from the NPs, the interaction of bacteria surface with fluorescent NPs was studied after 10 min of exposure at 37 C and pH 7.4 by flow cytometry. After bacterial incubation with fluorescent NPs, a new particle population with stronger relative fluorescence was displayed in the SSC versus FSC plot (Fig. 4) . Controls suggest that this third event population is due to the attachment of fluorescent NPs to the bacteria. Therefore, it can be concluded that our new NP formulation is able to attach to the bacterial cells and, thus, is able to release the drug on the bacterial surface for a period. Dillen et al. [39] reported that negatively charged PLGA NPs were is able to be adsorbed to P. aeruginosa surfaces in about 20 % of the examined cells, while only about 3 % of the E. coli cells were able to adsorb the NPs.
Biofilm cells
Particle penetration in the biofilm and drug release close to the site of infection can highly influence the efficacy of treatment [31] . The most important factors in NP interaction with biofilms are the size and surface charge of the NPs [40, 41] . To study the interaction of the herein developed FANPs with 1-day-old biofilm cells, CLSM was used after staining with FITC-linked ConA. This lectin was selected by its high specificity for mannose residues present in the bacterial glycocalyx and biofilm matrix [22, 38] . The obtained images showed a heterogeneously stained matrix (Fig. 5) . Dark areas within the biofilm can be due to the presence of water channels, the heterogeneous production of the matrix or the absence of ConA-FITC binding to the matrix [42] . These CLSM studies verified the homogeneous NP distribution all over the biofilm and their penetration to the deepest parts of the biofilm as the NPs could be easily found even on the surface of the Calgary biofilm device after 1 h of exposure (Fig. 5) .
In sum, the described amikacin-loaded PLGA NP formulation is able to distribute uniformly all along the biofilm thickness. The better penetration of the NPs in comparison to free drug can be due to the NP negative charge and the resulting electrostatic interaction. These results are in agreement with those found by Meers et al. [31] , who synthesized an amikacin-loaded liposome formulation and investigated its interaction with 4-day-old P. aeruginosa biofilms formed in flow cells. They found that positively charged liposomes in comparison to neutral or negatively charged ones are less able to penetrate inside the biofilms due to electrostatic interactions [31] .
NP uptake by mouse macrophages As stated, the chronic infections related to P. aeruginosa mostly depend on the biofilm formation and intracellular bacteria because of their inherent resistance to antimicrobial agents. Macrophages are a common target for P. aeruginosa cells. However, aminoglycosides have restricted cellular penetration due to their high hydrophilicity. Therefore, herein, we studied the in vitro interaction of the generated A-NPs with macrophages.
Cell viability and toxicity assay
There are a variety of assay methods that can be used to estimate the toxicity of a drug formulation. These assays are influenced by a large number of factors, including culture medium characteristics, cell density, incubation temperature, chemical interactions between culture medium components, test compound and assay chemistry and, finally, concentration and incubation time of the test compound [43] . Therefore, in this work, we used different indirect techniques to assess cell membrane integrity after particle exposure (dye exclusion: neutral red), quantification of the release of cytoplasmic markers (lactate dehydrogenase) and techniques to quantify metabolic markers (intracellular redox indicators: MTT, Alamar blue). Alamar blue (resazurin) is a water-soluble but cell permeable redox indicator used to study the ability of metabolically active cells to convert this blue dye indicator into a fluorescent red form. The advantage of MTT is based on its solubility, and besides that, resazurin can be reduced not only by NADPH, FADH, FMNH and NADH but also by the cytochromes, being then more sensitive. Using these four assays, no toxicity was detected for free drug and A-NPs (0.01-1 mg ml
À1
) against macrophage RAW 264.7. Hence, NP uptake by macrophages was studied by flow cytometry.
Flow cytometry analysis
Interaction among NPs and macrophages was monitored using flow cytometry through modifications in cell size (FSC) and granularity (SSC). No significant differences in FSC were detected after incubation at 4 or 37 C. However, flow cytometric SSC parameters increased for cells which had been incubated for 24 h at 37 C in comparison to 2 h. These results are in accordance with a location on the cell membrane at 4 C, whereas at 37 C, FA-NPs are internalized in more than 98 % of macrophages (Fig. 6) .
Generally, NP uptake by cells is an energy-dependent mechanism [44] . As a result, a significant difference between NP uptake at 4 and 37 C was expected. In addition, it was shown that NP interaction with macrophages and their uptake can be influenced by particle size, surface charge, hydrophobicity/hydrophilicity, temperature and duration of NP exposure to cells. On the other hand, NP uptake by macrophages is a dose-dependent process, and after a specific period, macrophages cannot uptake more particles [45] . Therefore, no more particle uptake after 2 h of incubation can be the result of cell saturation by particles at that period. As described here, the highest interaction of cells with NPs happened after 2 h of incubation, which can be an advantage for NP application in order to deliver the drug to the cells. To verify flow cytometry analysis results, NP uptake by macrophages was investigated using CLSM.
CLSM studies CLSM studies showed that after 2 h incubation at 4 C, NPs were mostly attached to the macrophage cell surfaces and rarely entered the cells. After 24 h of incubation, some NPs were able to enter the cells, as shown before by flow cytometry. However, the corresponding CLSM images showed that cell membrane labelling after 24 h at 4 C was not as glowing as the cells incubated at 37 C, suggesting that the NP presence in the cells could be from membrane leakage and not active uptake. The physicochemical characteristics of NPs can influence their uptake by macrophages [45] [46] [47] . According to electrostatic interactions, positively charged NPs are more likely to be taken up by macrophage cells, but these particles are generally considered to be more toxic than negatively charged NPs [48] [49] [50] . However, our results indicate that the herein synthesized amikacin-loaded PLGA NPs are successfully taken up by the macrophages after 2 h of incubation. Further studies are required in this area to verify their potential use to deliver the antibiotic directly to infected macrophages.
CONCLUSIONS
Antibiotic release at or near the site of infection can enhance the treatment efficacy, especially in the case of cationic drugs like aminoglycosides which are able to easily interact with a negatively charged biofilm matrix. Thus, the herein reported amikacin-loaded PLGA NP formulation, showing a worthy drug loading, drug release kinetic, size and antibacterial and antibiofilm activities, coupled with its lack of cytotoxicity, makes it a good candidate for development as C. Panel f shows the uptake distribution after flow cytometry analysis (maximum uptake, %) following 2 or 24 h exposure of macrophages to red fluorescent NPs at 4 or 37 C (n=3). For CLSM studies, the cell membrane was labelled using Vybrant DiO (green). The black holes inside the cells represent the cell nucleus.
an antibiofilm treatment for P. aeruginosa infection. Likewise, the ability to attach to and being internalized by macrophages supports its use to treat intracellular bacteria.
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